Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kurt Samson
Phase 2 Nilotinib Trials for Parkinsonʼs Yield Conflicting Efficacy Results
Neurology Today
Related publications
Exposure‐Response Relationships for Efficacy and Safety of Risankizumab in Phase 2 and 3 Trials in Psoriasis Patients
Clinical Pharmacology and Therapeutics
Pharmacology
A Trivariate Continual Reassessment Method for Phase I/Ii Trials of Toxicity, Efficacy, and Surrogate Efficacy
Statistics in Medicine
Epidemiology
Statistics
Probability
Neuropsychiatric Safety With Liraglutide 3.0 Mg for Weight Management: Results From Randomized Controlled Phase 2 and 3a Trials
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Safety and Efficacy of Pasireotide in Dumping Syndrome-Results From a Phase 2, Multicentre Study
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials
Headache
Neurology
Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials
Current Diabetes Reviews
Endocrinology
Metabolism
Diabetes
Multicenter Phase II Clinical Trial of Nilotinib for Patients With Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia From the East Japan CML Study Group Evaluation of Molecular Response and the Efficacy and Safety of Nilotinib
Biomarker Research
Biochemistry
Molecular Medicine
Clinical Biochemistry
A Combined Analysis of Immunogenicity, Antibody Kinetics and Vaccine Efficacy From Phase 2 Trials of the RTS,S Malaria Vaccine
BMC Medicine
Medicine
MDMA-assisted Psychotherapy for Treatment of PTSD: Study Design and Rationale for Phase 3 Trials Based on Pooled Analysis of Six Phase 2 Randomized Controlled Trials
Psychopharmacology
Pharmacology
